HeartSciences (HSCS) Accounts Payables (2022 - 2025)

HeartSciences' (HSCS) quarterly Accounts Payables came in at $318661.0 in Q4 2025, little changed on a QoQ basis from $317390.0 in Q4 2025.

HeartSciences (HSCS) Accounts Payables (2022 - 2025) Analysis & Trends

HeartSciences (HSCS) has 4 years of Accounts Payables data on file, last reported at $318661.0 in Q4 2025.

Quarterly Accounts Payables changed N/A year-over-year to $318661.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $318661.0 (changed N/A YoY) and the FY2025 annual result came in at $318661.0, down 28.9% from the prior year.
Accounts Payables held at $318661.0 in Q4 2025, from $317390.0 in the prior quarter.
In the past five years, Accounts Payables ranged from a high of $1.1 million in Q4 2023 to a low of $276848.0 in Q4 2024.
A 4-year average of $521285.9 and a median of $431629.5 in 2024 frame the typical range for Accounts Payables.
Annual changes were most pronounced in 2023 — Accounts Payables surged 36.85% — and 2024, when it plunged 74.56%.
Tracing HSCS's Accounts Payables over 4 years: stood at $795266.0 in 2022, then surged by 36.85% to $1.1 million in 2023, then sank by 74.56% to $276848.0 in 2024, then increased by 15.1% to $318661.0 in 2025.
The last three Accounts Payables figures came in at $318661.0 (Q4 2025), $317390.0 (Q4 2025), and $283225.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Accounts Payables (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	4.79 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	1.66 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	2.64 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	1.23 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	210.50 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	3.23 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	2.42 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	344.10 Mn
10	HeartSciences	6.54 Mn	4.84 Mn	-	-

Download Data